Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1986 May;29(5):948–950. doi: 10.1128/aac.29.5.948

Pharmacokinetic study of lenampicillin (KBT-1585) in healthy volunteers.

A Saito, M Nakashima
PMCID: PMC284190  PMID: 3729355

Abstract

The pharmacokinetic properties of lenampicillin (KBT-1585), a new ampicillin ester, were investigated in 41 healthy volunteers. The maximum concentration of ampicillin in serum after oral administration of 400 mg of lenampicillin was 6.5 micrograms/ml at 0.70 h, and that after a equimolar dosage of ampicillin was 2.9 micrograms/ml at 0.87 h.

Full text

PDF
948

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bodin N. O., Ekström B., Forsgren U., Jalar L. P., Magni L., Ramsay C. H., Sjöberg B. Bacampicillin: a new orally well-absorbed derivative of ampicillin. Antimicrob Agents Chemother. 1975 Nov;8(5):518–525. doi: 10.1128/aac.8.5.518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Clayton J. P., Cole M., Elson S. W., Ferres H. BRL.8988 (talampicillin), a well-absorbed oral form of ampicillin. Antimicrob Agents Chemother. 1974 Jun;5(6):670–671. doi: 10.1128/aac.5.6.670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Jones K. H. Bioavailability of talampicillin. Br Med J. 1977 Jul 23;2(6081):232–233. doi: 10.1136/bmj.2.6081.232-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Jones K. H., Langley P. F., Lees L. J. Bioavailability and metabolism of talampicillin. Chemotherapy. 1978;24(4):217–226. doi: 10.1159/000237784. [DOI] [PubMed] [Google Scholar]
  5. Leigh D. A., Reeves D. S., Simmons K., Thomas A. L., Wilkinson P. J. Talampicillin: a new derivative of ampicillin. Br Med J. 1976 Jun 5;1(6022):1378–1380. doi: 10.1136/bmj.1.6022.1378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Neu H. C. The pharmacokinetics of bacampicillin. Rev Infect Dis. 1981 Jan-Feb;3(1):110–116. doi: 10.1093/clinids/3.1.110. [DOI] [PubMed] [Google Scholar]
  7. Saito A., Kato Y., Murakami K. [Studies on talampicillin. I. Absorption and excretion--comparison with ampicillin and effects of food intake]. Kansenshogaku Zasshi. 1975 Jul;49(11):458–469. doi: 10.11150/kansenshogakuzasshi1970.49.458. [DOI] [PubMed] [Google Scholar]
  8. Sjövall J., Magni L., Bergan T. Pharmacokinetics of bacampicillin compared with those of ampicillin, pivampicillin, and amoxycillin. Antimicrob Agents Chemother. 1978 Jan;13(1):90–96. doi: 10.1128/aac.13.1.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Sommers D. K., van Wyk M., Moncrieff J., Schoeman H. S. Influence of food and reduced gastric acidity on the bioavailability of bacampicillin and cefuroxime axetil. Br J Clin Pharmacol. 1984 Oct;18(4):535–539. doi: 10.1111/j.1365-2125.1984.tb02501.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Welling P. G. Influence of food and diet on gastrointestinal drug absorption: a review. J Pharmacokinet Biopharm. 1977 Aug;5(4):291–334. doi: 10.1007/BF01061694. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES